Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 1, 2005, Pages 13-16

  Uneke, C J ^a   Ogbu, O ^a   Inyama, P U ^b   Anyanwu, G I ^b   Njoku, M O ^c   Idoko, J H ^b  

^a EBONYI STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF JOS   (Nigeria)

^c GEDE AIDS Infect Dis Res Inst   (Nigeria)

Author keywords

Hepatitis B virus; Human immunodeficiency; Prevalence; Virus blood donor

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; COMPARATIVE STUDY; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEX DIFFERENCE; VIRUS DETECTION;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 15244346810     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762005000100002     Document Type: Article

References (13)

1. Dienstag JL, Isselbacher KJ 1998. Chronic hepatitis. In AS Fauci, E Braunwald, KJ Isselbacher (eds), Harrison's Principles of Internal Medicine, Vol. 1, 14 th ed., Mc-Graw-Hill, New York, p. 1696-1704.
2. Drosten C, Nippraschk T, Manegold C, Meisel H, Brixner V, Roth WK, Apedjinou A, Gunther S 2004. Prevalence of hepatitis B virus DNA in anti-HBC-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol 29: 59-68.
3. Ekpo M, Sasegbon H, Oyewole F 1995. HIV and HBV serostatus of non- intravenous drug users in Lagos, Nigeria. Nig Med J 29: 35-36.
4. Fauci AS, Lane HC 1998. Human immunodeficiency virus (HIV) disease: AIDS and related disorders. In AS Fauci, E Braunwald, KJ Isselbacher (eds), Harrison's Principles of Internal Medicine, Vol. 1, 14 th ed., Mc-Graw-Hill, New York, p. 718-724.
5. Federal Ministry of Health Nigeria 2003. National HIV/AIDS and Reproductive Health Survey, Abuja, 209 pp.
6. Finlayson MDC, Hayes PC, Simpson KJ 1999. Diseases of the liver and biliary system: hepatitis. In C Haslett, ER Chilvers, JAA Hunter (eds), Davidson's Principles and Practice of Medicine, Churchill Living Stone, London, p. 706-715.
7. Hodges M, Sanders E, Aitken C 1998. Seroprevalence of hepatitis markers: HAV, HBV, HCV, and HBV amongst primary school children in Freetown Sierra Leone. W Afr J Med 17: 3-7.
8. Osmond DH 1994. HIV disease progression from infection to CDC defined AIDS. In PT Cohen, MA Sande, PA Volberding (eds), The AIDS Knowledge Base, Little Brown, New York, p. 1.7: 11-1.7:19.
9. Sirisena ND, Njoku MO, Idoko JA, Isamade E, Barau C, Jelpe D, Zamani A, Otowo S 2002. Carriage rate of hepatitis-B surface antigen (HbsAG) in an urban community in Jos, Plateau State, Nigeria. Nig Postgrad Med J 9: 7-10.
10. Treitinger A, Spada C, Ferreira LA, Neto MS, Reis M, Verdi JC, de Miranda AF, de Oliveira OV, Van der Sander SM, Abdalla DS 2004. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianopolis, Brazil. Braz J Infect Dis 4: 192-196.
11. UNAIDS 2000. Report of the Global HIV/AIDS Epidemics, Geneva.
12. UNSN 2001. Nigerian Common Country Assessment, World Health Organization, Geneva, 563 pp.
13. WHO 2003. Global Health-sector Strategy for HIV/AIDS 2003-2007, Geneva, 32 pp.